Armstrong Says FDA "Assured" OTC Access Of Reformulated Primatene Mist

Armstrong Pharmaceuticals says FDA "assured" the firm that it can sell a proposed reformulated epinephrine inhaler OTC, if approved, despite opponents who say asthma relief is an inappropriate self-medication indication